Home - EVŌQ
Developing an antimicrobial therapeutic platform that demonstrates efficacy against the world’s worst superbugs.
EVQ-218, our lead asset, has shown early indications as a safe, broad-spectrum, antimicrobial solution for use in therapeutics and medical devices.
The leadership team of EVŌQ Bio has over 50 years combined experience in healthcare and biotechnology research, in addition to years of leadership, management, and consulting experience. As a team, we are uniquely situated to break new ground in the advancement of next-generation biotechnology and pharmaceuticals.
Home - EVŌQ